Kardigan, Inc.

NASDAQ:KARD

Biotechnology

Healthcare
$12.32 +3.50%

+$0.77 today

Market cap
$1.10B
Beta
0.00
52W Low $16.25High $24.00

Volume 0.55M

Average 5.84M

KARD Other Non-Cash Items

Other non-cash adjustments that reconcile net income to operating cash flow.

No reported Other Non-Cash Items figures are available to summarize.

Other Non-Cash Items history

Currency unavailable · from the cash flow

No Other Non-Cash Items data reported for this period type.

Other Non-Cash Items vs competitors

How KARD compares with its peers on the latest reported figures

KARD Competitors
Other Non-Cash Items for KARD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CYTKCytokinetics, IncorporatedLTM Jun 2026$233.97M USD+224.8%+46.0%329.7%
NAMSNewAmsterdam Pharma Company N.V.LTM Jun 2026$28.88M USD-225.3%-38.7%405.5%
TNYATenaya Therapeutics, Inc.LTM Mar 2026$2.91M USD-18.3%+10.3%1291.1%
IKTInhibikase Therapeutics, Inc.LTM Mar 2026$2.33M USD-137.7%+322.3%—
RNAAtrium Therapeutics, Inc.FY2025$712K USD——3.8%
KARDKardigan, Inc.—— ———
Peer median (excluding KARD) —-78.0%+28.2%367.6%

Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kardigan, Inc.

NASDAQ:KARD

Intrinsic Alpha fair value

Locked

Current Price

$12.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.